Skip to content

Clinical trials

Completed Hemophilia B trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia B Status: Completed Country / region: Belgium Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20081
20092
20101
20111
20121
20141
20182
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cliniques universitaires Saint-Luc- Université Catholique de Louvain3
Bioverativ Therapeutics Inc.2
Wyeth is now a wholly owned subsidiary of Pfizer2
CSL Behring1
Centre Hospitalier Universitaire de Liege1
Janssen Research & Development, LLC1
Novo Nordisk A/S1
Pfizer1
Swedish Orphan Biovitrum1
Universiteit Antwerpen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia B14
Hemophilia A9
Joint Diseases2
Adrenal Hyperplasia, Congenital1
Adrenoleukodystrophy1
Andersen Syndrome1
Anemia, Diamond-Blackfan1
Anemia, Sickle Cell1
Argininosuccinic Aciduria1
Aspartylglucosaminuria1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.